Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

JAIME MEDRANO MD PA

NPI: 1902385453 · WESLACO, TX 78596 · Pediatrics Physician · NPI assigned 08/07/2018

$302K
Total Medicaid Paid
15,009
Total Claims
11,791
Beneficiaries
41
Codes Billed
2019-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMEDRANO, JAIME (PHYSICIAN)
NPI Enumeration Date08/07/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 80 $3K
2020 337 $6K
2021 2,431 $51K
2022 3,313 $74K
2023 1,714 $38K
2024 7,134 $129K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,438 3,750 $119K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1,049 994 $32K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,309 1,098 $29K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,854 1,743 $20K
90460 Immunization administration through 18 years of age via any route, first or only component 1,706 735 $18K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 219 216 $16K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 568 526 $12K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 142 140 $12K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 141 138 $11K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 92 88 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 132 127 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,118 1,043 $5K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 91 83 $5K
87428 33 31 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 94 92 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 31 31 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 87 86 $2K
97169 22 20 $657.60
96110 Developmental screening, with scoring and documentation, per standardized instrument 46 42 $390.17
87807 47 45 $275.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 12 12 $229.25
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 12 12 $229.25
87581 14 14 $196.50
96160 92 90 $78.09
90686 83 82 $35.99
81003 30 29 $24.57
81002 12 12 $20.44
90671 51 51 $0.08
90620 36 36 $0.04
90707 27 27 $0.00
90734 12 12 $0.00
90715 12 12 $0.00
90681 13 13 $0.00
90461 135 114 $0.00
90670 12 12 $0.00
90633 17 17 $0.00
90716 28 28 $0.00
90697 31 31 $0.00
90656 111 109 $0.00
90619 32 32 $0.00
90651 18 18 $0.00